Finucane Anne A. bought CVS

November 20, 2025 · Form 4 insider transaction

Finucane Anne A. bought 1,775.381 shares of CVS Health Corporation at $76.04 per share, a transaction worth $135.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
1,775.381
Price
$76.04
Total value
$135.0K
Role—
SecurityDeferred Stock Units
Transaction codeA: Grant or award
Transaction dateNovember 20, 2025
Filing dateNovember 21, 2025
Shares owned after16,530
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.; Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.

View the original Form 4 on SEC EDGAR